PLC/PRF/5, Galunisertib, rep3

Accession: GSM6502636 
Description:
PLC/PRF/5 cells treated with Galunisertib - Replicate 3 Source GEO sample is GSM6502636 Last updated (according to GEO): Jun 01 2023
Experiments used in: Gene expression profiling in hepatocellular carcinoma cell lines PRC/PRF/5 and SNU-449 after a treatment with Transforming Growth Factor beta (TGF-beta) and Galunisertib, alone or in combination, Subset for PLC/PRF/5 cell
Sample: GSE211806_Biomat_4
Platform: GPL21185 - Agilent-072363 SurePrint G3 Human GE v3 8x60K Microarray 039494 [Probe Name Version]